Skip to main content

Table 6 Severity grading of reported adverse events following praziquantel treatment among S. mansoni-infected pre-school children

From: Efficacy and safety of praziquantel treatment against Schistosoma mansoni infection among pre-school age children in southern Ethiopia

Type of AEs

Total number of AEs

Grade1 (Mild)

Grade2 (Moderate)

Grade3 (Severe)

Stomachache

27

20 (74.1%)

6 (22.2%)

1 (3.7%)

Diarrhea

19

17 (89.5%)

2 (10.5%)

 

Nausea

18

16 (88.9%)

2 (11.1%)

 

Drowsiness

17

15 (88.2%)

2 (11.8%)

 

Fever

17

16 (94.1%)

1 (5.9%)

 

Vomiting

16

13 (81.2%)

3 (18.8%)

 

Dizziness

15

13 (86.7%)

2 (13.3%)

 

Loss of appetite

14

14 (100%)

  

Headache

13

13 (100%)

  

Confusion

5

5 (100%)

  

Cough

3

3 (100%)

  

Itching

3

3 (100%)

  

Other symptoms

2

2 (100%)

  

Total

169

150 (88.8%)

18 (10.6%)

1 (0.6%)

  1. N: Total number of AEs within each type; AEs: Adverse events